Pigmentation Clinical Trial
Official title:
Evaluation of the Efficacy and Safety of PiQo4 for the Treatment of Hand Pigmentation Using 1064nm PSL and 532nm PSL
A total of 20 healthy subjects at a single site, aged 21-70 years old with congenital or acquired challenging/resistant, age/sun-related flat and benign hand pigmentation who wish to improve their skin appearance.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | April 2022 |
Est. primary completion date | April 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 70 Years |
Eligibility | Inclusion Criteria: - Healthy Female/Male. - Age= 21-70 (Adults). - Fitzpatrick skin phototype = I-V - Congenital or acquired benign pigmentation on hands. - Presence of at least three (3) lesions with similar pigmentation intensity in the treatment area in diameters larger than 2 mm. - Able to read, understand and provide written Informed Consent. - Able and willing to comply with the treatment/follow-up schedule and requirements. - Women of child-bearing potential are required to use a reliable method of birth control (such as an intrauterine device, birth control pills, condom with spermicidal, NuvaRing, partner with vasectomy, Implanon or other FDA-approved devices, or abstinence) during the course of the study. Exclusion Criteria: - History of post inflammatory pigmentary disorders, particularly a tendency for hyper- or hypo-pigmentation. - Tanning (artificial or natural) 1 month prior first treatment and during the entire study duration including follow-up. - Excessive underlying vascular conditions (e.g. dense network of capillaries). - Pregnant, intending to become pregnant during the course of study, less than 3 months postpartum or less than 3 months after completion of breastfeeding. - Prior skin laser, light or other energy device treatment in treated area within 6 months of initial treatment or during the course of the study. - Prior ablative resurfacing procedure in treated area with laser or other devices within 12 months of initial treatment or during the course of the study. - Prior treatment with medium-depth or deeper, chemical peels or dermabrasion in treated area within 3 months of initial treatment or during the course of the study. - Any other surgery in treated area within 9 months of initial treatment or during the course of the study. - Hypersensitive to light exposure or the use of photosensitive medication for which light exposure is contraindicated. - Multiple dysplastic nevi or suspicious pigmentation in area to be treated. - Presence of underlying tattoo in the treatment area. - Significant concurrent illness (e.g. uncontrolled diabetes) or any disease state that in the opinion of the Investigator would interfere with the treatment or healing process. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | "Sk;N" Clinic | London |
Lead Sponsor | Collaborator |
---|---|
Focus Medical, LLC |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hands pigmentation change assessed by investigator | Hands pigmentation change assessed by investigator at the 1 month follow up using the 5-point Pigment Improvement Score where score of between 0 and 4 will be assigned (0- No improvement in pigmentation, 1- Trace to mild improvement of some lesions, 2- Moderate response: some lesions lighter, 3- Good response: most lesions much lighter and 4- Excellent response- Most or all lesions much lighter or gone. | 1 month follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05913102 -
A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin
|
N/A | |
Completed |
NCT05750914 -
Evaluation of Broadband Light Treatment for Pigmented Skin Lesions
|
N/A | |
Recruiting |
NCT06074276 -
The Effects of Almond on Facial Skin Collagen and Wrinkles
|
N/A | |
Completed |
NCT05662592 -
Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study
|
N/A | |
Recruiting |
NCT05847530 -
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
|
N/A | |
Enrolling by invitation |
NCT01847066 -
Epidermal Delivery of Ani-Aging Ingredients
|
N/A | |
Completed |
NCT03065582 -
The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects
|
N/A | |
Completed |
NCT03565146 -
Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions
|
N/A | |
Completed |
NCT04493021 -
Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions
|
N/A | |
Terminated |
NCT02506101 -
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo
|
N/A | |
Not yet recruiting |
NCT05160103 -
16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects
|
N/A | |
Completed |
NCT06075641 -
Post Gingival Depigmentation Assessment: Comparison of Surgical Stripping vs (Er,Cr:YSGG) Laser
|
N/A | |
Completed |
NCT01885091 -
Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage
|
Phase 4 | |
Completed |
NCT05710068 -
Effects of RF Microneedle on Photoaging Skin
|
N/A | |
Completed |
NCT05304624 -
Comparison of Er,Cr:YSGG Laser and Diode Laser in the Treatment of Gingival Melanin Pigmentation
|
N/A | |
Recruiting |
NCT04866797 -
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure
|
N/A | |
Recruiting |
NCT04865094 -
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure
|
N/A | |
Completed |
NCT04881058 -
Post Market Clinical Follow Up Study to Collect Additional Data and Imaging
|
N/A | |
Completed |
NCT03970317 -
Safety and Efficacy of Broad Band Light In Motion Treatment
|
N/A |